General Information of Drug (ID: DM10A9S)

Drug Name
6-Chloro-N-(2-morpholinoethyl)nicotinamide Drug Info
Synonyms
6-Chloro-N-(2-morpholinoethyl)nicotinamide; CHEMBL596768; 446269-58-5; 6-chloro-N-[2-(morpholin-4-yl)ethyl]pyridine-3-carboxamide; AC1LNWHD; Oprea1_139589; MLS001010907; CTK6H1374; cid_1228702; 6-chloro-N-(2-morpholin-4-ylethyl)pyridine-3-carboxamide; MolPort-000-431-678; HMS2765K07; ZINC19397174; BDBM50307188; AKOS000162940; MCULE-8413919053; SMR000352965; ST50046456; 6-chloro-N-(2-morpholin-4-ylethyl)nicotinamide; Z32410126; F1077-0095
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
1228702
TTD Drug ID
DM10A9S

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Monoamine oxidase type A (MAO-A) TT3WG5C AOFA_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Monoamine oxidase type A (MAO-A) DTT MAOA 7.207 8.159 9.043 7.711
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Monoamine oxidase type A (MAO-A) DTT MAOA 8.14E-01 0.05 0.1
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1659-64.